Devin Trejo

Devin Trejo is a pharmaceutical industry professional currently serving as the Director of Global Product Development in Oncology Early Development at Pfizer.5 His role focuses on oncology drug development, particularly in the early stages of clinical trials and product development.13

Some key points about Devin Trejo:

Professional Experience

• Current Position: Director, Global Product Development, Oncology Early Development at Pfizer45
• Previous Role: Oncology Feasibility Lead in Development Operations at Pfizer's Feasibility Center of Excellence12

Expertise

• Oncology drug development
• Clinical trial planning and operations
• Global product development strategies

Education

Trejo holds an MBA degree, which likely contributes to his business and management skills in the pharmaceutical industry.1

Industry Involvement

Trejo has been involved in industry conferences and discussions, particularly around:

• Converting clinical pipelines into virtual trials
• Addressing challenges in oncology-based clinical trials
• Evaluating the impact of COVID-19 on cancer patient health and clinical trials3

While specific details about Trejo's career history and personal background are limited in the provided information, his current role at Pfizer and involvement in oncology drug development indicate he is a seasoned professional in the pharmaceutical industry with a focus on advancing cancer treatments through clinical research and development.